Current Challenges With Somatostatin Analogues in Neuroendocrine Tumors

Opinion
Video

Panelists discuss how somatostatin analogues, while effective in controlling hormone-related symptoms and tumor growth in neuroendocrine tumors, face challenges including drug resistance, optimal dosing strategies, and timing of initiation in the treatment sequence.

Recent Videos
3 experts in this video
3 experts in this video
3 experts in this video
3 experts in this video
Vinay K. Puduvalli, MD, is featured in this series.
3 experts in this video
3 experts in this video
Related Content